From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following Brexit
- Resource Type
- Review Article
- Source
- In
The Lancet Oncology April 2023 24(4):e150-e160 - Subject
Review and Opinion Policy Review - Language
- ISSN
- 1470-2045